Whether You’Re A Newly Diagnosed Brain Tumor Patient, A Survivor, Or A Friend Or Relative Of Either, This Book Offers Help. The Only Text To Provide Both The Doctor’S And Patient’S Point Of View, 100 Questions & Answers About Brain Tumors Gives You Authoritative, Practical Answers To Your Questions About Treatment Options, Post-Treatment Quality Of Life, Sources Of Support, And Much More. The Authors, A Brain Tumor Survivor Teamed With A Neuro-Oncologist Specializing In Brain Tumors, Provide A Comprehensive, Step-By-Step Discussion Of What You Can Expect In The Diagnosis And Treatment Of Brain Tumors, While Providing A Real-Life Understanding Of What These Steps Might Mean For Your Day-To-Day Life. This Book Is An Invaluable Resource For Anyone Coping With The Physical And Emotional Turmoil Of This Frightening Disease.
Searching Book Reviews.
Author. Date: 16 Jun 2010, Views:
Richard Prayson, MD, Bette K.leinschmidt-Demasters, Mark R. Cohen, quot;Brain Tumorsquot;
Demos Medical Publishing | 2009 | ISBN: 1933864699 | 336 pages | File type: PDF | 50,6 mb
quot;The Consultant Pathologyquot; series is designed to disseminate the knowledge of expert surgical pathology consultants in the analysis and diagnosis of difficult cases to the full community of pathology practitioners. The volumes are based on actual consultations and presented in a format that illustrates the expert's process of evaluating the case, including indications for consultation, the consultant's findings and comment, and discussion of the entity that amplifies the case description. Each volume in the quot;Consultant Pathologyquot; series is authored by international experts with extensive case experience in the areas covered.
Surgical neuropathology is a challenging arena for many pathologists, due in large part to a relative lack of experience of most pathologists in this area compared to other areas of surgical pathology. Consultant Pathology: Brain Tumors is intended to address this need with cases drawn from the surgical neuropathology practices of the authors.
This volume provides examples of over 100 brain tumors, running the gamut from the very common to the rare. Each example is presented in a case based format and the wide variety of cases presented covers the entire scope of brain tumors and offers the opportunity to review both the basics for the beginner or relatively inexperienced pathologist and also offers experienced pathologists the chance to see some of the rare entities.
Each case is formatted as if it were a consult case and includes a brief clinical history, description of the pathologic findings with numerous illustrations, the line diagnosis, discussion of the entity, and the diagnostic thought process as well pertinent references for further reading. When relevant, current practical applications of immunohistochemistry and molecular pathology are discussed.
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.
Date: 2010-11-13 22:12:50
Brain Sync Super Pack -Kelly Howell-
Label: Self-help | ISBN n/a | Language: English | Audio CD in MP3 /192Kbps + PDF version's | 762 MB
Brain Sync CDs have been clinically tested with a record-breaking 95% success rate and are offered to patients at America's most prestigious cancer treatment hospitals, Memorial Sloan Kettering and Dana Farber.
Details Download now
Date: 2014-07-23 05:37:48
Change Your Brain, Change Your Body: Use Your Brain to Get and Keep the Body You Have Always Wanted
DVDrip, MP4 @ 656 Kbps, 720 x 416, 14.985 fps + Audio CD, MP3 @ 174 Kbps, 2 channels | ISBN-10: 0739384910 | 1.24 GB
Genre: Hypnosis, Meditation, Health | Also included: Questionnaires (JPEG) | Author: Daniel G. Amen M.D. | Language: English
The key to a better body is a healthy brain. Based on the latest medical research, as well as on Dr. Amen’s two decades of clinical practice at the renowned Amen Clinics, Change Your Brain, Change Your Body shows you how to take the very best care of your brain.
Date: 2016-04-12 16:15:59
David Douglas, "Brain Training: How to Train Your Brain Health with Neuroplasticity and Brain Plasticity"
2016 | EPUB | 36 pages | ISBN: 1530001374 | English | 0.1 MB
Date: 2016-02-17 08:42:14
"Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors" ed. by Terry Lichtor
ITAe | 2013 | ISBN: 9789535110583 | 652 pages | PDF | 33 MB
In this book a review of the options available for the clinical management of patients with these tumors are outlined. In addition advances in radiology both for pre-operative diagnostic purposes along with surgical planning are described. A review of newer developments in chemotherapy along with the evolving field of photodynamic therapy both for intra-operative management and subsequent therapy is provided. Details Download now
Date: 2015-02-04 10:42:52
Michael J. Lavery - Whole Brain Power: The Fountain of Youth for the Mind and Body
88 MP3 @ 24.0 Kbps. 13 DOC, 49 PDF | ISBN: n/a | Language: English | 545 MB
Genre: Mindset / Achievement
If you are new to Whole Brain Power and want to enjoy a Better Memory * Higher Mood Elevation * A Deeper Night Sleep * Bolder Confidence In Social Situations * Super-Powered Attention * Razor Sharp Focus * Greater Functional Strength * Better Language & Verbal Communication * Less Stress * Faster Reaction Time In Athletics and Greater Control and Steadiness In Your Hands, you need to consider this groundbreaking new information below. Details Download now
Date: 2015-01-17 16:16:51
Buddha's Brain: The Practical Neuroscience of Happiness, Love & Wisdom (Audiobook)
MP3 @ 60.5 Kbps (2ch) | ISBN-10: 1491518669, ASIN: B004CDDLBG | Duration: 6 hours and 58 minutes | 190 MB
Author: Rick Hanson Ph.D. | Language: English
The Buddha and other great teachers were born with brains built essentially like anyone else's - and then they changed their brains in ways that changed the world. Science is now revealing how the flow of thoughts actually sculpts the brain. By combining breakthroughs in neuroscience with insights from thousands of years of contemplative practice, you, too, can use your mind to shape your brain for greater happiness, love, and wisdom. Details Download now
Date: 2014-02-22 14:14:15
"Traumatic Brain Injury" ed. by Farid Sadaka
InTAvE | 2014 | ISBN: 9535112228 9789535112228 | 570 pages | PDF | 18 MB
This book provides an excellent and detailed overview of the management of patients with traumatic brain injury, in a stepwise approach, from the intensive care unit, through to discharge from the hospital, rehabilitation, recovery and assimilation in family and society Details Download now
Date: 2014-01-11 19:52:02
We Are Our Brains: A Neurobiography of the Brain, from the Womb to Alzheimer's by D. F. Swaab and Jane Hedley-Prole
English | 2014 | ISBN: 0812992962 | ISBN-13: 9780812992960 | 448 pages | EPUB | 5,3 MB
A vivid account of what makes us human.
Based groundbreaking new research, We Are Our Brains is a sweeping biography of the human brain, from infancy to adulthood to old age. Details Download now
Date: 2013-06-19 16:06:50
John Morgan Allman, "Evolving Brains"
English | 1999 | ISBN: 0716750767, 071676038X | 224 pages | PDF | 57,7 MB
How did the human brain with all its manifold capacities evolve from basic functions in simple organisms that lived nearly a billion years ago? John Allman addresses this question in Evolving Brains, a provocative study of brain evolution that introduces readers to some of the most exciting developments in science in recent years. Details Download now
Date: 2016-10-03 00:39:22
Sex on the Brain: 12 Lessons to Enhance Your Love Life
Audio CDs in MP3 / English: MP3, 64 kb/s (2 ch) | Duration: 08:22:05 | 2007 | ISBN-10: 1400154022
Size: 230 Mb | Genre: Psychology, Sex
"The vast majority of love and sex occurs in the brain. Your brain decides who is attractive to you, how to get a date, how well you do on the date, what to do with the feelings that develop, how long those feelings last, when to commit, and how well you do as a partner and a parent.
A brain tumor is a collection, or mass, of abnormal cells in your brain. Your skull, which encloses your brain, is very rigid. Any growth inside such a restricted space can cause problems. Brain tumors can be cancerous (malignant) or non-cancerous (benign). When benign or malignant tumors grow, they can cause the pressure inside your skull to increase. This can cause brain damage, and it can be life-threatening.
Brain tumors are categorized as primary or secondary. A primary brain tumor originates in your brain. Many primary brain tumors are benign. A secondary brain tumor, also known as a metastatic brain tumor, occurs when cancer cells spread to your brain from another organ, such as your lung or breast.Types of Brain Tumors
Primary Brain Tumors
Primary brain tumors originate in your brain. They can develop from your:
Primary tumors can be benign or cancerous. In adults, the most common types of brain tumors are gliomas and meningiomas.Gliomas
Gliomas are tumors that develop from glial cells. These cells:
Gliomas develop from a variety of glial cells.
The types of tumors that begin in glial cells are:
Most meningiomas and schwannomas occur in people between the ages of 40 and 70. Meningiomas are more common in women than men. Schwannomas occur equally in both men and women. These tumors are usually benign, but they can cause complications because of their size and location. Cancerous meningiomas and schwannomas can be very aggressive.Other Primary Brain Tumors
Other primary brain tumors include:
Secondary brain tumors make up the majority of brain cancers. They start in one part of the body and spread, or metastasize, to the brain. The following can metastasize to the brain:
Secondary brain tumors are always malignant. Benign tumors don’t spread from one part of your body to another.What Are the Risk Factors for a Brain Tumor?
As the fastest growing consumer health information site — with 65 million monthly visitors — Healthline’s mission is to be your most trusted ally in your pursuit of health and well-being.
You can depend on us to provide expert content along with genuine caring. Both of which will support, guide, and inspire you toward the best possible health outcomes for you and your family.
Sign Up for Health Tips
A confirmation email has been sent, and you will receive our next newsletter soon!
Get our latest health and wellness advice delivered right to your inbox.
Your privacy is important to us
Marry M. van den Heuvel-Eibrink, MD, PhD
Wilms tumor is a rare kidney cancer that is usually diagnosed in children under the age of six. Wilms tumor is mostly the result of aberrations in WT1 gene, located on chromosome 11p13. In addition to being a risk factor for Wilms tumor, WT1 aberrations cause extra renal complications and other malignancies. This book brings together the basic and clinical aspects of Wilms tumor and WT1 research under three sections. Section I provides a comprehensive guide to the epidemiology, diagnostics, management, and treatment of Wilms tumor. Section II covers the biological aspects of Wims tumor and WT1. Section III focuses on the role of WT1 in cardiac development, prostate cancer, glioblastoma and minimal residual disease.
About the Volume editor: Marry M. van den Heuvel-Eibrink, MD, PhD
Professor Marry M. van den Heuvel-Eibrink, MD, PhD, is a senior consultant in pediatric oncology and hematology at the Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands, where she is responsible for the now established centralized care and translational research program for all children with renal tumors in the Netherlands. She is the current Chair of the European Working Group on Myelodysplastic Syndromes (EWOG-MDS) foundation, and the Dutch Childhood Oncology Group (DCOG) renal tumor committee. She is the co-chair of the International Society of Paediatric Oncology-Renal Tumour Study Group (SIOP-RTSG), steering committee member of the DCOG late effects consortium, and an active member of IBFM-AML study group. From 1997-2014 she was a senior consultant at the Erasmus MC-Sophia Children’s Hospital, Rotterdam. During this period, she was the Working Group leader of the Erasmus MC Postgraduate Molecular Medicine School, which is recognized by the Dutch Royal Academy of Science and Arts. Her major research interest is translational research in pediatric cancer, with a special focus on renal tumors, and the (genetic) variation of early and late childhood cancers. Professor van den Heuvel-Eibrink has published over 260 international peer reviewed manuscripts and is the supervisor of over 25 finalized and ongoing PhD projects.
Bengt Sandstedt. Pages ix-xi
Marry M. van den Heuvel-Eibrink. Pages xiii-xv
Exciting new developments and discoveries of the last two decades are beginning to shed light on the complex biology of brain tumors and are advancing our understa- ing of the cellular and molecular processes involved in their initiation, progression, and clinical and biological behavior. The disease process in brain tumors is quite complex and the resulting tumors are characterized by a high degree of biological and clinical diversity. Thus, despite the advances of the last two decades, prognosis for patients with malignant brain tumors remains abysmal. Significant progress in the diagnosis, treatment and, ultimately, prevention of these tumors will require both the timely h- nessing of the advances in basic and clinical brain tumor research, and a continuing concerted effort at increasing our understanding of brain tumor biology, in particular, the molecular genetic changes and perturbations of cellular pathways involved in brain oncogenesis and which drive the biological and clinical behavior of the tumors. Brain tumor diagnosis and prognosis, which is still largely based on histopathology and other clinical criteria, will, in the future, acquire a significant molecular component, with the incorporation of knowledge of genes that are mutated, over-expressed, deleted, silenced, or functionally altered in the tumors. Treatment strategies for brain tumors, rather than being empirical, will be rationally developed based on an understanding of the cellular and molecular mechanisms and targets that have been activated, suppressed, or otherwise altered.
Bunu varsayılan liste yap.
Öğeler başarıyla eklendi
Öğeler eklenirken hata oldu. Lütfen tekrar deneyiniz.
Data usage warning: You will receive one text message for each title you selected.
Standard text messaging rates apply.
Text it to me, and go to next item
Hacettepe Üniversitesi Kütüphaneleri
Copyright 2011 SirsiDynix - Portfolio Version 4.3 (29506)
When you are diagnosed with a serious illness, like a spinal cord or brain tumor. learning about survival rates and prognosis for your condition can make you panic even more. But, it’s important to keep in mind that survival rates are simply statistics ; they do not apply to one specific person.
Statistics are gathered about a group of patients with a certain disorder, such as a brain tumor, within a certain time frame. In general, to get an accurate statistic it’s necessary to have a relatively large group of people. But spinal cord and brain tumors are very rare forms of cancer, accounting for less than 2 percent of all cancers. This small number of patients makes it difficult for statisticians to gather and analyze information.
In addition, there are more than 120 types of brain tumors, making an already difficult job harder. So, while it is important to know about survival rates for spinal cord and brain tumors, don't rely too heavily on the numbers. Your situation may be different.
The best source for specific information for your individual prognosis is your own doctor. Have a candid discussion with your doctor about your long-term outlook.
Brain Tumor Prognosis: The Stats
As you read the rates below, remember that these numbers are not guarantees, but a general idea of the severity of some types of brain tumors.
Based on information collected from 2000 to 2004, for people diagnosed with a primary malignant brain and spinal cord tumor (including lymphoma and leukemia. tumors of the pituitary and pineal glands, and tumors of the nose), the five-year survival rates are 28.8 percent for males and 31.6 percent for females. A five-year survival rate refers to the proportion of people who are still alive five years following a diagnosis.
When those five-year survival rates were further broken down by age at diagnosis, the relative survival rates were:
A relative survival rate refers to survival odds compared with other U.S. citizens within the same category who do not have a malignant tumor.
Brain Tumor: Survival Rates for Meningiomas
People with meningiomas, the most common form of brain tumor, had a five-year survival rate of 69 percent. When broken down further, survival rate for people with benign (non-cancerous) meningiomas was 70 percent but, for people with malignant (cancerous) meningiomas, the rate was 55 percent.
Brain Tumor: Survival Rates for Glioblastomas
About 19 percent of all primary brain tumors are glioblastomas, the most common type of cancerous brain tumors.
People with glioblastomas had very low relative survival rates: Less than 4 percent lived five years after diagnosis. The survival rate for some children and adolescents may be up to 25 percent if surgery is effective, but since this is not common, most children with glioblastomas have the same odds as adults.
Brain Tumor: Gender and Race
As a rule, men get more brain tumors than women, for reasons that are not clear. But, women get more tumors of certain types.
Overall, Caucasians get more brain tumors, such as glioblastoma, than African-Americans; about twice as many. But African-Americans get more tumors of the meninges. The cause of this disparity is not known.
Reasons to be Hopeful
There are good reasons to be hopeful about the prognosis for spinal cord and brain tumors. Brain tumors are an important research topic; a search on the National Cancer Institute’s Web site for adult glioblastoma clinical trials turned up 249 trials that are recruiting patients.
Progress is also being made in the operating room. “Because of new techniques and technology, neurosurgeons can see, reach, and remove tumors that we could never reach before,” says Andrew Sloan, MD, director of the Brain Tumor and Neuro-oncology Center at University Hospitals Case Medical Center in Cleveland. “We are making a great deal of progress.”
Brain Tumor: More Information
A good source for spinal cord and brain tumor survival rates is the Surveillance, Epidemiology, and End Results program (SEER) Cancer Statistics Review (CSR). which reports statistics regarding cancer and is published annually by the Cancer Statistics Branch of the National Cancer Institute.
Last Updated: 6/1/2009
Springer Science+Business Media B.V. 2011. — 385 p. — ISBN 978-94-007-1398-7.
In this volume, as in volumes 1 and 2, the emphasis is on the diagnosis, therapy, and prognosis of brain tumors. In addition to describing strategies for advanced brain tumor treatment, this volume presents information on understanding the unique biology of the brain and its tumors. The information contained in this volume should aid in the development of tools for better diagnosis and effective treatment of brain malignancy.
The application of various imaging techniques, including MRI, MRSI, PET, and CT, for diagnosing brain tumors including peripheral nerve sheath tumors is detailed. The use of MRS modality for classifying brain tumors is presented. This volume also contains information on the passage of malignancy to brain from tumors of other organs such as female breast and lung (tumor to tumor).
The inception of both primary and secondary brain tumors is discussed. Also is included the delivery of drugs into brain tumors, considering the presence of blood brain barrier. A wide variety of treatments, such as conventional chemotherapy, electrochemotherapy, conventional resection, stereotactic radiosurgery, and magnetic resonance-guided focused ultrasound surgery in clinical practice, are explained in detail. The use of radioresponsive gene therapy for malignant brain tumors is included in this volume. The use of molecular markers as predictive and prognostic indicators in treatment decisions for individual cases are already beginning to have a significant positive effect on the clinical practice. A number of such markers are discussed in the volume. This volume also discusses pain management following craniotomy, antiepileptic drugs, and quality of life after brain tumor therapy and follow-up.
M.A. Hayat Introduction
Juan M. García-Gómez Brain Tumor Classification Using Magnetic Resonance Spectroscopy
Ruman Rahman and Richard G. Grundy Cellular Immortality in Brain Tumors: An Overview
Tumor to Tumor Passage of Malignancy
Jian-Qiang Lu and Arthur W. Clark Tumor-to-Tumor Metastasis: Extracranial TumorMetastatic to Intracranial Tumors
Kazuhiko Ogawa, Shogo Ishiuchi and Sadayuki Murayama Brain Metastases from Breast Cancer: Treatment and Prognosis
Aida Loudyi and Wolfram E. Samlowski Brain Metastasis in Renal Cell Carcinoma Patients
Naveen Sankhyan, Suvasini Sharma and Sheffali Gulati Coexsistence of Inflammatory Myofibroblastic Tumor in the Lung and Brain
Jonas M. Sheehan and Akshal S. Patel Breast Cancer and Renal Cell Cancer Metastases to the Brain
Andreas M. Stark Breast Cancer Brain Metastases: Genetic Profiling and Neurosurgical Therapy
Stephanie Sutherland and Stephen Johnston Central Nervous System Tumours in Women Who Received Capecitabine and Lapatinib Therapy for Metastatic Breast Cancer
Biomarkers and Diagnosis
Theri Leica Degaki, Marcos Angelo Almeida Demasi and Mari Cleide Sogayar Functional Role of the Novel NRP/B Tumor Suppressor Gene
Karl-Josef Langen, Matthias Weckesser and Frank Floeth Brain Tumors: Diagnostic Impact of PET Using Radiolabelled Amino Acids
Andre A. le Roux and Abhijit Guha Malignant Peripheral Nerve Sheath Tumors: Use of 18FDG-PET/CT
Hanna Järnum, Linda Knutsson and Elna-Marie Larsson Brain Tumors: Evaluation of Perfusion Using 3D-FSE-Pseudo-Continuous Arterial Spin Labeling
Robert Shenkar, Sameer A. Ansari and Issam A. Awad Cerebral Cavernous Malformations: Advanced Magnetic Resonance Imaging
Jan Luts, Teresa Laudadio, Albert J. Idema, Arjan W. Simonetti, Arend Heerschap, Dirk Vandermeulen, Johan A.K. Suykens and Sabine Van Huffel Nosologic Imaging of Brain Tumors Using MRI and MRSI
Kosuke Shimizu and Naoto Oku Brain Tumor Diagnosis Using PET with Angiogenic Vessel-Targeting Liposomes
Richard Prayson Frozen Section Evaluation of Central Nervous System Lesions
Richard Hummel, Jessica Maurer and Joerg Haier Clinical Role of MicroRNAs in Different Brain Tumors
Mette Linnert, Birgit Agerholm-Larsen, Faisal Mahmood, Helle K. Iversen and Julie Gehl Electrochemotherapy for Primary and Secondary Brain Tumors
Anne-Laure Laine, Emilie Allard, Philippe Menei and Catherine Passirani Brain Tumors: Convection-Enhanced Delivery of Drugs (Method)
Ameer L. Elaimy, Alexander R. MacKay, Wayne T. Lamoreaux, Robert K. Fairbanks, John J. Demakas, Barton S. Cooke, Benjamin J. Arthurs and Christopher M. Lee Brain Metastases: Clinical Outcomes for Stereotactic Radiosurgery (Method)
Ernst Martin and Ferenc A. Jolesz Noninvasive Treatment for Brain Tumors: Magnetic Resonance-Guided Focused Ultrasound Surgery
Laurent Menard Radioguided Surgery of Brain Tumors
Murielle Mimeault and Surinder K. Batra Implications of Mutant Epidermal Growth Factor Variant III in Brain Tumor Development and Novel Targeted Therapies
Pawel G. Ochalski and Johnathan A. Engh Endoscopic Port Surgery for Intraparenchymal Brain Tumors
Paul Ronning, Torstein Meling, Siril Rogne and Eirik Helseth Intracranial Tumor Surgery in Elderly Patients
Jason P. Sheehan and Edward M. Marchan Intracranial Hemangiopericytoma: Gamma Knife Surgery
Jesse J. Savage and Jason P. Sheehan Stereotactic Radiosurgery for Cerebral Metastases of Digestive Tract Tumors
Hideo Tsurushima and Akira Matsumura Malignant Brain Tumors: Role of Radioresponsive Gene Therapy
Cristina D’Angelo, Antonio Mirijello, Giovanni Addolorato and Vincenzo Antonio D’Angelo Brain Tumors: Quality of Life
Eefje M. Sizoo and Martin J.B. Taphoorn Health-Related Quality of Life in Patients with High Grade Gliomas
Sophie Dupont Epilepsy and Brain Tumours and Antiepileptic Drugs
Youngmee Kim Familial Caregivers of Patients with Brain Cancer
Doug Hughes and Scott Y. Rahimi Pain Management Following Craniotomy
Peter Lindvall and Tommy Bergenheim Air Transportation of Patients with Brain Tumours
Tags: ebook brain tumor